Revista de la Sociedad Argentina de Diabetes (Sep 2022)

Can prevent type 1 diabetes?

  • Gustavo Frechtel

DOI
https://doi.org/10.47196/diab.v56i3Sup.590
Journal volume & issue
Vol. 56, no. 3Sup
pp. 51 – 51

Abstract

Read online

Type 1 diabetes (T1D) is caused by the autoimmune destruction of β cells of the pancreas, driven by CD4+ and CD8+ T lymphocytes. The humoral branch represented by B lymphocytes is responsible for producing autoantibodies (AAs) against specific antigens such as glutamate decarboxylase (GADA), cellular membrane phosphatase (IA2A/ICA512A), zincT8 transporter (ZincT8A), and the insulin molecule (IAA), all markers of the autoimmune process. These AAs can be detected before the clinical onset of T1D, at the prediabetes type 1 stage (1). The overall risk of progression to T1D is regarded as the presence of 2 or more AAs but differs across patients, being higher with a greater number of AAs (2).

Keywords